Nourish Raises $100 Million Series C to Reverse Chronic Disease with AI-Native Metabolic Clinic

Nourish, the country’s largest dietitian-led metabolic health clinic, led by Aidan Dewar, Stephanie Liu, and Sam Perkins, has announced its $100 million Series C, bringing total funding to $215 million. The round was led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners. With this investment, J.P. Sanday of Menlo Ventures will join the board.

The funding will be used to grow Nourish’s clinical network, accelerate investment in AI agents for patients and providers, expand its metabolic clinic care model, and deepen partnerships with health plans, employers, and health systems.

“Chronic disease is the largest cost driver in U.S. healthcare, yet the system isn’t built to treat it,” said Aidan Dewar, Co-Founder and CEO of Nourish. “We’ve built the care model and technology to drive behavior change and deliver better outcomes at lower cost, and this funding allows us to scale that impact.”

Nearly 200 million Americans live with nutrition-related chronic conditions, driving nearly $5 trillion in annual U.S. healthcare costs and over one million preventable deaths.

Nourish addresses this through an AI-native metabolic clinic focused on behavior change and measurable outcomes, delivering clinically significant improvements and over $2,000 in annual savings per patient.

Every patient at Nourish works with a virtual Registered Dietitian and receives a coordinated care plan that may include lab testing, medication management, and support integrated with existing providers.

Each patient also has an AI health agent that supports behavior change and care coordination, while provider-facing AI copilots surface insights and automate administrative work to improve care quality.

The rise of GLP-1 medications has driven demand for metabolic care, but medication alone is often insufficient, with low long-term adherence and weight regain after discontinuation. Payers are seeking scalable, durable solutions.

Nourish combines GLP-1 prescribing with a nutrition-first care model focused on sustained behavior change and long-term outcomes.

Founded four years ago, Nourish has scaled to a network of over 10,000 Registered Dietitians, completed millions of appointments, and more than tripled year-over-year.

The company partners with hundreds of major health plans covering over 200 million lives and works with tens of thousands of providers across 250+ health systems, supporting hundreds of thousands of patient referrals.

“Chronic disease is the central failure of U.S. healthcare, nearly 200 million Americans affected and trillions spent with limited improvement in outcomes,” said J.P. Sanday, Partner at Menlo Ventures. “Nourish has built a care model that bends the cost curve, combining scale, payer partnerships, and strong clinical outcomes. We’re proud to lead this round.”